GR81450B - - Google Patents

Info

Publication number: GR81450B
Authority: GR; Greece

Application number

GR75111A

Inventor

Davis L Temple

Walter G Lobeck

Original Assignee

Bristol Myers Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-06-29

Filing date

1984-06-26

Publication date

1984-12-11

1984-06-26 Application filed by Bristol Myers Co filed Critical Bristol Myers Co

1984-12-11 Publication of GR81450B publication Critical patent/GR81450B/el

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C265/00—Derivatives of isocyanic acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/067—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Psychiatry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Quinoline Compounds (AREA)
Pyridine Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

GR75111A 1983-06-29 1984-06-26 GR81450B (el)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/509,266 US4487773A (en)	1981-03-16	1983-06-29	1,2,4-Triazol-3-one antidepressants

Publications (1)

Publication Number	Publication Date
GR81450B true GR81450B (el)	1984-12-11

Family

ID=24025922

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR75111A GR81450B (el)	1983-06-29	1984-06-26

Country Status (21)

Country	Link
US (1)	US4487773A (el)
JP (1)	JPS6036469A (el)
KR (1)	KR890000637B1 (el)
AU (1)	AU579826B2 (el)
BE (1)	BE900038A (el)
CA (1)	CA1255310A (el)
CH (2)	CH663412A5 (el)
DE (1)	DE3423898A1 (el)
DK (1)	DK316784A (el)
ES (1)	ES533753A0 (el)
FI (1)	FI842597A (el)
FR (1)	FR2551439B1 (el)
GB (4)	GB2142631B (el)
GR (1)	GR81450B (el)
IT (1)	IT1176342B (el)
LU (1)	LU85442A1 (el)
MY (1)	MY102072A (el)
NL (1)	NL8402028A (el)
PT (1)	PT78816A (el)
SE (1)	SE8403460L (el)
ZA (1)	ZA844887B (el)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
YU44721B (en) *	1983-11-30	1990-12-31	Bristol Myers Co	Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone
US4596884A (en) *	1983-11-30	1986-06-24	Bristol-Myers Company	4-(2-phenoxyethyl)-1,2,4-triazolone process intermediates
DE3934081A1 (de) *	1989-10-12	1991-04-18	Bayer Ag	Sulfonylaminocarbonyltriazolinone
US4784998A (en) *	1987-04-06	1988-11-15	Bristol-Myers Company	1,3,4-oxadiazole pyschotropic compounds
EP0350145A3 (en) *	1988-04-28	1990-07-04	Yamanouchi Pharmaceutical Co. Ltd.	Pyridylthiazolidine carboxamide derivatives and their intermediates and production of both
FR2642759B1 (fr) *	1989-02-09	1991-05-17	Laboratorios Esteve Sa	Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
US5243051A (en) *	1990-03-05	1993-09-07	Shionigi & Co., Ltd.	Tetrahydropyridine derivatives
US5149817A (en) *	1990-03-05	1992-09-22	Shionogi & Co., Ltd.	Teirahydropyridine derivatives
US5266571A (en) *	1992-01-09	1993-11-30	Amer Moh Samir	Treatment of hemorrhoids with 5-HT2 antagonists
US5256664A (en) *	1992-04-28	1993-10-26	Bristol-Myers Squibb Company	Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
DE4425144A1 (de) *	1994-07-15	1996-01-18	Basf Ag	Triazolverbindungen und deren Verwendung
CA2160423A1 (en) *	1994-11-02	1996-05-03	Hemant N. Joshi	Salts of nefazodone having improved dissolution rates
US6403593B1 (en)	1995-07-14	2002-06-11	Abbott Laboratories	Triazole compounds and the use thereof
DE19728996A1 (de)	1997-07-07	1999-01-14	Basf Ag	Triazolverbindungen und deren Verwendung
DE69928542T2 (de)	1998-09-18	2006-03-30	Alcon Manufacturing Ltd., Fort Worth	5HT2-Agonisten zur Behandlung des Glaukoms
ES2152860B1 (es)	1998-10-23	2001-08-16	Finaf 92 Sa	Forma cristalina de la nefazodona y procedimiento para su preparacion.
ES2188344B1 (es) *	2000-11-29	2004-09-16	Laboratorios Vita, S.A.	Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos.
MXPA05003830A (es) *	2002-10-11	2005-06-23	Cytokinetics Inc	Compuestos, composiciones y metodos.
AU2004236195A1 (en) *	2003-04-30	2004-11-18	Bayer Cropscience Ag	Phenyl substituted cyclic derivatives
EP1737473A4 (en) *	2004-04-19	2009-08-26	Noven Therapeutics Llc	COMBINATIONS OF LITHIUM AND USES THEREOF
AR049382A1 (es) *	2004-05-18	2006-07-26	Fmc Corp	Derivados de la urea ciclica substituida
US20060073172A1 (en) *	2004-10-01	2006-04-06	Schneider L W	Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
JP5358571B2 (ja) *	2007-08-07	2013-12-04	プロサリクリミテッド	セロトニン作動性調節因子としての１，２，４−トリアゾール誘導体
US8686158B2 (en) *	2008-06-05	2014-04-01	President And Fellows Of Harvard College	High-valent palladium fluoride complexes and uses thereof
KR20110095898A (ko)	2008-11-20	2011-08-25	프레지던트 앤드 펠로우즈 오브 하바드 칼리지	유기 화합물의 플루오르화
JP2012514655A (ja) *	2009-01-09	2012-06-28	プレジデントアンドフェローズオブハーバードカレッジ	フッ素含有化合物およびその使用法
EP2697204B1 (en)	2011-04-12	2017-03-08	President and Fellows of Harvard College	Fluorination of organic compounds
EP2822931B1 (en)	2012-03-09	2017-05-03	Inception 2, Inc.	Triazolone compounds and uses thereof
WO2014052622A1 (en)	2012-09-26	2014-04-03	President And Fellows Of Harvard College	Nickel fluorinating complexes and uses thereof
CN104918922B (zh)	2012-12-20	2017-04-26	因森普深2公司	三唑酮化合物及其用途
EP2990082B1 (en)	2013-04-26	2017-06-07	Nippon Takkyu Co., Ltd.	Table tennis ball and table tennis ball-use thermoplastic resin composition
WO2015035059A1 (en)	2013-09-06	2015-03-12	Inception 2, Inc.	Triazolone compounds and uses thereof
US10759764B2 (en)	2013-10-18	2020-09-01	President And Fellows Of Harvard College	Fluorination of organic compounds
WO2023218251A1 (en) *	2022-05-10	2023-11-16	Clearsynth Labs Limied	Novel deuterium-enriched nefazodone analogues and method for preparing thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1066857B (it) *	1965-12-15	1985-03-12	Acraf	Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
IT1052119B (it) *	1972-10-16	1981-06-20	Sigma Tau Ind Farmaceuti	Derivati del triazolinone e procedimento per la loro preparazione
IT1052130B (it) *	1973-10-15	1981-06-20	Sigma Tau Ind Farmaceuti	Derivati del triazolinone e procedimento per la loro preparazione
US4338317A (en) *	1981-03-16	1982-07-06	Mead Johnson & Company	Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
US4386091A (en) *	1982-02-24	1983-05-31	Mead Johnson & Company	2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants
US4613600A (en) *	1983-09-30	1986-09-23	Mead Johnson & Company	Antidepressant 1,2,4-triazolone compounds

1983
- 1983-06-29 US US06/509,266 patent/US4487773A/en not_active Expired - Fee Related
1984
- 1984-06-26 GR GR75111A patent/GR81450B/el unknown
- 1984-06-26 ZA ZA844887A patent/ZA844887B/xx unknown
- 1984-06-27 FR FR848410136A patent/FR2551439B1/fr not_active Expired
- 1984-06-27 CA CA000457534A patent/CA1255310A/en not_active Expired
- 1984-06-27 ES ES533753A patent/ES533753A0/es active Granted
- 1984-06-27 NL NL8402028A patent/NL8402028A/nl not_active Application Discontinuation
- 1984-06-27 FI FI842597A patent/FI842597A/fi not_active Application Discontinuation
- 1984-06-27 AU AU29953/84A patent/AU579826B2/en not_active Ceased
- 1984-06-28 CH CH1910/87A patent/CH663412A5/de not_active IP Right Cessation
- 1984-06-28 PT PT78816A patent/PT78816A/pt not_active IP Right Cessation
- 1984-06-28 KR KR1019840003692A patent/KR890000637B1/ko not_active IP Right Cessation
- 1984-06-28 SE SE8403460A patent/SE8403460L/xx not_active Application Discontinuation
- 1984-06-28 IT IT21641/84A patent/IT1176342B/it active
- 1984-06-28 GB GB08416435A patent/GB2142631B/en not_active Expired
- 1984-06-28 LU LU85442A patent/LU85442A1/fr unknown
- 1984-06-28 BE BE0/213240A patent/BE900038A/fr not_active IP Right Cessation
- 1984-06-28 CH CH3130/84A patent/CH662562A5/de not_active IP Right Cessation
- 1984-06-28 DE DE19843423898 patent/DE3423898A1/de not_active Ceased
- 1984-06-28 DK DK316784A patent/DK316784A/da not_active Application Discontinuation
- 1984-06-29 JP JP59133401A patent/JPS6036469A/ja active Granted
1987
- 1987-02-17 GB GB08703634A patent/GB2185021B/en not_active Expired
- 1987-02-17 GB GB08703633A patent/GB2184447B/en not_active Expired
- 1987-02-17 GB GB08703632A patent/GB2184446A/en not_active Withdrawn
- 1987-09-29 MY MYPI87002184A patent/MY102072A/en unknown

Also Published As

Publication number	Publication date
GB2184447B (en)	1988-02-03
US4487773A (en)	1984-12-11
GB8703632D0 (en)	1987-03-25
GB2142631A (en)	1985-01-23
FI842597A0 (fi)	1984-06-27
ES8600278A1 (es)	1985-10-01
CH662562A5 (de)	1987-10-15
GB8703634D0 (en)	1987-03-25
GB2184446A (en)	1987-06-24
PT78816A (en)	1984-07-01
NL8402028A (nl)	1985-01-16
JPH0524151B2 (el)	1993-04-06
IT8421641A0 (it)	1984-06-28
AU579826B2 (en)	1988-12-15
CA1255310A (en)	1989-06-06
GB2185021B (en)	1988-02-03
KR890000637B1 (ko)	1989-03-22
AU2995384A (en)	1985-01-03
GB8416435D0 (en)	1984-08-01
JPS6036469A (ja)	1985-02-25
GB2184447A (en)	1987-06-24
FR2551439A1 (fr)	1985-03-08
GB2185021A (en)	1987-07-08
MY102072A (en)	1992-03-31
ZA844887B (en)	1985-02-27
BE900038A (fr)	1984-12-28
FR2551439B1 (fr)	1989-08-25
KR850000430A (ko)	1985-02-27
IT1176342B (it)	1987-08-18
DK316784A (da)	1984-12-30
GB8703633D0 (en)	1987-03-25
LU85442A1 (fr)	1985-03-26
IT8421641A1 (it)	1985-12-28
FI842597A (fi)	1984-12-30
GB2142631B (en)	1987-09-03
SE8403460L (sv)	1984-12-30
ES533753A0 (es)	1985-10-01
SE8403460D0 (sv)	1984-06-28
DK316784D0 (da)	1984-06-28
DE3423898A1 (de)	1985-01-03
CH663412A5 (de)	1987-12-15

Publication	Publication Date	Title
BR8407173A (el)	1985-10-08
GR81928B (el)	1984-12-12
GR81450B (el)	1984-12-11
AT378328B (el)	1985-07-25
AU1412583A (el)	1983-06-30
AU9008182A (el)	1983-04-14
BR6301293U (el)	1985-04-09
BG44936A1 (el)	1989-03-15
BG44974A1 (el)	1989-03-15
BG44583A1 (el)	1989-01-16
BG44584A1 (el)	1989-01-16
BG44586A1 (el)	1989-01-16
BG44587A1 (el)	1989-01-16
BG44648A1 (el)	1989-01-16
BG44651A1 (el)	1989-01-16
BG44655A1 (el)	1989-01-16
BG44700A1 (el)	1989-01-16
BG44760A1 (el)	1989-02-15
BG44763A1 (el)	1989-02-15
BG44795A1 (el)	1989-02-15
BG44882A1 (el)	1989-03-15
BG44897A1 (el)	1989-03-15
BG44913A1 (el)	1989-03-15
BG44566A1 (el)	1989-01-16
BG44937A1 (el)	1989-03-15